What are the latest figures on the resorbable vascular scaffolds market’s size and projected CAGR?
The resorbable vascular scaffolds market size has grown rapidly in recent years. It will grow from $0.46 billion in 2024 to $0.52 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, increasing consumer health awareness, rising prevalence of coronary artery disease (CAD), increasing adoption of minimally invasive procedures, and increasing prevalence of diabetes.
The resorbable vascular scaffolds market size is expected to see rapid growth in the next few years. It will grow to $0.83 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to growing risk of coronary artery disease (CAD) and peripheral artery disease (PAD) in the geriatric population, growing funding for research and development (R&D) of surgical procedures, growing aging population, increasing healthcare expenditure, and rising coronary artery disease prevalence. Major trends in the forecast period include inclination towards drug-eluting devices for angioplasty, technological advancements and product innovation, advancements in stent technology, advancements in stent technology, and advancements in diagnostic technologies.
Get Your Free Sample of The Global Resorbable Vascular Scaffolds Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21272&type=smp
Which Market drivers have played a significant role in driving the resorbable vascular scaffolds market?
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the resorbable vascular scaffolds market going forward. Cardiovascular diseases are driven by factors such as poor lifestyle choices, aging, high blood pressure, high cholesterol, diabetes, smoking, and genetic predispositions. Resorbable vascular scaffolds are revolutionizing the treatment of cardiovascular diseases by providing temporary structural support to restore blood flow while gradually dissolving, reducing long-term complications associated with permanent implants and promoting natural vessel healing and functionality. For instance, in September 2024, according to the Minnesota Department of Health, a US-based state agency, in 2023, 4% of adults in Minnesota, equating to nearly 180,000 people, had experienced a heart attack. Additionally, heart disease was responsible for approximately 17% of all deaths in the state, leading to 8,972 fatalities in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the resorbable vascular scaffolds market.
What are the key segments within the resorbable vascular scaffolds market?
The resorbable vascular scaffolds market covered in this report is segmented –
1) By Product Design: Multilumen, Single Lumen
2) By Material Type: Poly-Glycolic Acid, Poly-L-Lactic Acid, Poly-L-Lactic-Co-Glycolic Acid
3) By Deployment Technique: Balloon-Expandable, Self-Expandable
4) By Application: Coronary Artery Disease, Peripheral Vascular Disease, Pulmonary Artery Disease
5) By End User: Ambulatory Surgical Centers, Hospitals, Specialty Clinics
Subsegments:
1) By Multilumen: Helical Design, Braided Design, Other Multilumen Designs
2) By Single Lumen: Straight Tube Design, Corrugated Tube Design, Other Single Lumen Designs
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/resorbable-vascular-scaffolds-global-market-report
Which key players are shaping the resorbable vascular scaffolds market?
Major companies operating in the resorbable vascular scaffolds market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Getinge Group, Biotronik, LivaNova plc, Lepu Medical Technology, Gore Medical, Biosensors International, Blue Medical, Reva Medical, Elixir Medical, S3V Vascular Technologies, Amaranth Medical Inc., Meril Life Sciences Pvt. Ltd., Arterius Limited, Zorion Medical, Kyoto Medical Planning Co. Ltd., ICON Interventional Systems.
Which transformative trends will shape the resorbable vascular scaffolds market landscape?
Major companies operating in the resorbable vascular scaffolds market are developing magnesium scaffolds to improve biocompatibility and provide better mechanical support. Magnesium scaffolds promote natural vessel healing while reducing inflammation and complications associated with traditional polymer-based scaffolds. For instance, in March 2024, Biotronik, a Germany-based medical device company, received food and drug administration (FDA) breakthrough device designation for its Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). The Freesolve RMS is a breakthrough device designed for individuals with chronic limb-threatening ischemia (CLTI), offering an advanced treatment option for below-the-knee (BTK) interventions. It features BIOmag magnesium alloy and Orsiro drug-eluting stent (DES) coating technology, which enhances safety, deliverability, and vessel support. The scaffold provides short-term support to resist vessel recoil during healing.
How do regional factors impact the resorbable vascular scaffolds market, and which region is the largest contributor?
North America was the largest region in the resorbable vascular scaffolds market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the resorbable vascular scaffolds market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Resorbable Vascular Scaffolds Market Report 2025 Offer?
The resorbable vascular scaffolds market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Resorbable vascular scaffolds are medical devices used to treat vascular diseases by providing temporary structural support to blood vessels. Resorbable vascular scaffolds gradually dissolve after fulfilling their purpose, reducing the risks associated with permanent implants. By promoting natural vessel healing and restoring normal blood flow, they offer a safer and more effective alternative to traditional stents.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21272
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
